Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHRONIC-BRONCHITIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 932 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mario Eandi; Orietta Zaniolo
      Valore clinico ed economico di levofloxacina

      Farmeconomia e percorsi terapeutici
    2. Kim, JS; Hackley, GH; Okamoto, K; Rubin, BK
      Sputum processing for evaluation of inflammatory mediators

      PEDIATRIC PULMONOLOGY
    3. Helms, PJ
      Issues in pediatric asthma

      PEDIATRIC PULMONOLOGY
    4. Lomas, DA; Silverman, EK
      The genetics of chronic obstructive pulmonary disease

      RESPIRATORY RESEARCH
    5. Sunesson, AL; Gullberg, J; Blomquist, G
      Airborne chemical compounds on dairy farms

      JOURNAL OF ENVIRONMENTAL MONITORING
    6. Jeffery, PK
      Immunopathology: Comparison of COPD and asthma

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    7. Chung, KF
      Cytokines: An overview

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    8. Sarau, HM; Widdowson, KL; Palovich, MR; White, JR; Underwood, DC; Griswold, DE
      Interleukin-8 receptor (CXCR2) antagonists

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    9. Wigertz, A; Westerling, R
      Measures of prevalence: which healthcare registers applicable?

      SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
    10. Blondeau, JM
      Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Yassin, HM; Dever, LL
      Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Suadicani, P; Hein, HO; Meyer, HW; Gyntelberg, F
      Exposure to cold and draught, alcohol consumption, and the NS-phenotype are associated with chronic bronchitis: an epidemiological investigation of 3387 men aged 53-75 years: the Copenhagen Male Study

      OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    13. Ulvestad, B; Bakke, B; Eduard, W; Kongerud, J; Lund, MB
      Cumulative exposure to dust causes accelerated decline in lung function intunnel workers

      OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    14. Jacobs, MR
      Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters

      CLINICAL MICROBIOLOGY AND INFECTION
    15. Ruchlin, HS; Dasbach, EJ
      An economic overview of chronic obstructive pulmonary disease

      PHARMACOECONOMICS
    16. Cazzola, M; Matera, MG; Tufano, MA; Catalanotti, P; Polverino, M; Cantoni, V; Fici, F; Sarlo, F; Rossi, F
      Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study

      JOURNAL OF CHEMOTHERAPY
    17. Ball, P; Wilson, R; Mandell, L; Brown, J; Henkel, T
      Efficacy of gemifloxacin in acute exacerbations of chromic bronchitis: a randomised, double-blind comparison with trovafloxacin

      JOURNAL OF CHEMOTHERAPY
    18. Bousquet, J; Demoly, P; Michel, FB
      Specific immunotherapy in rhinitis and asthma

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    19. Seemungal, T; Harper-Owen, R; Bhowmik, A; Moric, I; Sanderson, G; Message, S; MacCallum, P; Meade, TW; Jeffries, DJ; Johnston, SL; Wedzicha, JA
      Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    20. Kanner, RE; Anthonisen, NR; Connett, JE
      Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease - Results fromthe Lung Health Study

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    21. Prieto, A; Reyes, E; Bernstein, ED; Martinez, B; Monserrat, J; Izquierdo, JL; Callol, L; de Lucas, P; Alvarez-Sala, R; Alvarez-Sala, JL; Villarrubia, VG; Alvarez-Mon, M
      Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferon)

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    22. Saetta, M; Turato, G; Maestrelli, P; Mapp, CE; Fabbri, LM
      Cellular and structural bases of chronic obstructive pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    23. Aaron, SD; Angel, JB; Lunau, M; Wright, K; Fex, C; Le Saux, N; Dales, RE
      Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    24. Sakao, S; Tatumi, K; Igari, H; Shino, Y; Shirasawa, H; Kuriyama, T
      Association of tumor necrosis factor alpha gene promoter polymorphism withthe presence of chronic obstructive pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    25. Cook, D; Guyatt, G; Wong, E; Goldstein, R; Bedard, M; Austin, P; Ramsdale, H; Jaeschke, R; Sears, M
      Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    26. Pilette, C; Godding, V; Kiss, R; Delos, M; Verbeken, E; Decaestecker, C; De Paepe, K; Vaerman, JP; Decramer, M; Sibille, Y
      Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    27. Paladino, JA
      Is more than one quinolone needed in clinical practice?

      ANNALS OF PHARMACOTHERAPY
    28. Weiss, K; Restieri, C; Gauthier, R; Laverdiere, M; McGeer, A; Davidson, RJ; Kilburn, L; Bast, DJ; de Azavedo, J; Low, DE
      A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae

      CLINICAL INFECTIOUS DISEASES
    29. Ho, PL; Tse, WS; Tsang, KWT; Kwok, TK; Ng, TK; Cheng, VCC; Chan, RMT
      Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study

      CLINICAL INFECTIOUS DISEASES
    30. Schentag, JJ; Gilliland, KK; Paladino, JA
      What have we learned from pharmacokinetic and pharmacodynamic theories?

      CLINICAL INFECTIOUS DISEASES
    31. Krasemann, C; Meyer, J; Tillotson, G
      Evaluation of the clinical microbiology profile of moxifloxacin

      CLINICAL INFECTIOUS DISEASES
    32. Talan, DA
      Clinical perspectives on new antimicrobials: Focus on fluoroquinolones

      CLINICAL INFECTIOUS DISEASES
    33. Atis, S; Tutluoglu, B; Salepci, B; Ocal, Z
      Serum IgA and secretory IgA levels in bronchial lavages from patients witha variety of respiratory diseases

      JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY
    34. Campbell, BJ; Rowe, GE; Leiper, K; Rhodes, JM
      Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Gal beta 1-3GalNac alpha-) expression seen in colon cancer

      GLYCOBIOLOGY
    35. Poole, PJ; Black, PN
      Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review

      BRITISH MEDICAL JOURNAL
    36. Montnemery, P; Bengtsson, P; Elliot, A; Lindholm, LH; Nyberg, P; Lofdahl, CG
      Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group

      RESPIRATORY MEDICINE
    37. Lundback, B; Ronmark, E; Jonsson, E; Larsson, K; Sandstrom, T
      Incidence of physician-diagnosed asthma in adults - a real incidence or a result of increased awareness? Report from the Obstructive Lung Disease in Northern Sweden Studies

      RESPIRATORY MEDICINE
    38. Ekberg-Jansson, A; Andersson, B; Bake, B; Boijsen, M; Enanden, I; Rosengren, A; Skoogh, BE; Tylen, U; Venge, P; Lofdahl, CG
      Neutrophil-associated activation markers in healthy smokers relates to a fall in DLCO and to emphysematous changes on high resolution CT

      RESPIRATORY MEDICINE
    39. Ringbaek, T; Viskum, K
      Has the perception of disability among COPD patients applying for pension changed during the last 20 years?

      RESPIRATORY MEDICINE
    40. Larsson, LG; Lindberg, A; Franklin, KA; Lundback, B
      Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population

      RESPIRATORY MEDICINE
    41. Cazzola, M; Blasi, F; Allegra, L
      Critical evaluation of guidelines for the treatment of lower respiratory tract bacterial infections

      RESPIRATORY MEDICINE
    42. Loppow, D; Schleiss, MB; Kanniess, F; Taube, C; Jorres, RA; Magnussen, H
      In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation

      RESPIRATORY MEDICINE
    43. Zheng, L; Shum, IH; Tipoe, GL; Leung, R; Lam, WK; Ooi, GC; Tsang, KW
      Macrophages, neutrophils and tumour necrosis factor-alpha expression in bronchiectatic airways in vivo

      RESPIRATORY MEDICINE
    44. Ekberg-Jansson, A; Bake, B; Andersson, B; Skoogh, BE; Lofdahl, CG
      Respiratory symptoms relate to physiological changes and inflammatory markers reflecting central but not peripheral airways. A study in 60-year-old 'healthy' smokers and never-smokers

      RESPIRATORY MEDICINE
    45. Raza, MW; Bint, AT; Blackwell, CC
      Role of infection and cytokines in the pathogenesis of chronic obstructivepulmonary disease

      REVIEWS IN MEDICAL MICROBIOLOGY
    46. Ball, P; File, TM; Twynholm, M; Henkel, T
      Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    47. Akalin, HE
      The place of antibiotic therapy in the management of chronic acute exacerbations of chronic bronchitis

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    48. Nagata, T; Hara, K; Oka, T; Yamauchi, Y; Igarashi, K; Hazama, H; Omata, M
      Microscopic polyangiitis associated with sinobronchial syndrome

      INTERNAL MEDICINE
    49. Ferdousi, HA; Munir, AKM; Zetterstrom, O; Dreborg, SKG
      Seasonal differences of peak expiratory flow rate variability and mediators of allergic inflammation in non-atopic adolescents

      PEDIATRIC ALLERGY AND IMMUNOLOGY
    50. Hoidal, JR
      Genetics of COPD: present and future

      EUROPEAN RESPIRATORY JOURNAL
    51. Ishii, T; Keicho, N; Teramoto, S; Azuma, A; Kudoh, S; Fukuchi, Y; Ouchi, Y; Matsuse, T
      Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis

      EUROPEAN RESPIRATORY JOURNAL
    52. Meek, PM; Lareau, SC; Anderson, D
      Memory for symptoms in COPD patients: how accurate are their reports?

      EUROPEAN RESPIRATORY JOURNAL
    53. Cerveri, I; Accordini, S; Verlato, G; Corsico, A; Zoia, MC; Casali, L; Burney, P; de Marco, R
      Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults

      EUROPEAN RESPIRATORY JOURNAL
    54. Gompertz, S; O'Brien, C; Bayley, DL; Hill, SL; Stockley, RA
      Changes in bronchial inflammation during acute exacerbations of chronic bronchitis

      EUROPEAN RESPIRATORY JOURNAL
    55. Sala, E; Alegre, L; Carrera, M; Ibars, M; Orriols, FJ; Blanco, ML; Carceles, F; Bertran, S; Mata, F; Font, I; Agusti, AGN
      Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD

      EUROPEAN RESPIRATORY JOURNAL
    56. Chaouat, A; Weitzenblum, E; Kessler, R; Schott, R; Charpentier, C; Levi-Valensi, P; Zielinski, J; Delaunois, L; Cornudella, R; dos Santos, JM
      Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation

      EUROPEAN RESPIRATORY JOURNAL
    57. Miravitlles, M; Murio, C; Guerrero, T
      Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis

      EUROPEAN RESPIRATORY JOURNAL
    58. Montnemery, P; Svensson, C; Adelroth, E; Lofdahl, CG; Andersson, M; Greiff, L; Persson, CGA
      Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema

      EUROPEAN RESPIRATORY JOURNAL
    59. Radon, K; Danuser, B; Iversen, M; Jorres, R; Monso, E; Opravil, U; Weber, C; Donham, KJ; Nowak, D
      Respiratory symptoms in European animal farmers

      EUROPEAN RESPIRATORY JOURNAL
    60. Ramirez-Romero, R; Brogden, KA; Gallup, JM; Sonea, IM; Ackermann, MR
      Mast cell density and substance P-like immunoreactivity during the initiation and progression of lung lesions in ovine Mannheimia (Pasteurella) haemolytica pneumonia

      MICROBIAL PATHOGENESIS

    61. Revision of the IVth Consensus Conference on anti-infectious treatments ofFrench Society of Infectious Diseases (SPILF): Management of lower respiratory tract infections

      REVUE DES MALADIES RESPIRATOIRES
    62. Martinot, JB; Carr, WD; Cullen, S; Budo, JLH; Bauer, K; MacLeod, C; Sanguinetti, CM; van Veldhuizen, WCJ
      A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis

      ADVANCES IN THERAPY
    63. Lieberman, D; Lieberman, D; Ben-Yaakov, M; Lazarovich, Z; Hoffman, S; Ohana, B; Friedman, MG; Dvoskin, B; Leinonen, M; Boldur, I
      Infectious etiologies in acute exacerbation of COPD

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    64. Zuck, P
      Non antibiotic management of acute to chronic bronchitis, without considering respiratory insufficiency (non obstructive - and obstructive bronchitis).

      MEDECINE ET MALADIES INFECTIEUSES
    65. Gaillat, J; Dabernat, H
      Reassement of the Lille consensus on treatment of chronic bronchitis exacerbation

      MEDECINE ET MALADIES INFECTIEUSES
    66. Gaillat, J; Baranes, C; Amsellem, D; Cohen, A; Bougon, N; Riebbels, V; Chauveau, E
      Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis.

      MEDECINE ET MALADIES INFECTIEUSES
    67. Dalphin, JC
      Farmer's lung disease: new look and current concepts.

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    68. Contopoulos-Ioannidis, DG; Ioannidis, JPA; Chew, P; Lau, J
      Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections

      Journal of antimicrobial chemotherapy
    69. Yohannes, AM
      Pulmonary rehabilitation and outcome measures in elderly patients with chronic obstructive pulmonary disease

      GERONTOLOGY
    70. Belda, J
      Sputum induction for the diagnosis and monitoring of respiratory diseases

      ARCHIVOS DE BRONCONEUMOLOGIA
    71. Medeiros, RD; Faresin, SM; Jardim, JR
      Postoperative lung complications and mortality in patients with mild-to-moderate COPD undergoing elective general surgery

      ARCHIVOS DE BRONCONEUMOLOGIA
    72. Gonzalez-Mangado, N; Prat, JM
      Cell oxidative processes and antioxidant mucoactive

      ARCHIVOS DE BRONCONEUMOLOGIA
    73. Schaberg, T; Ballin, I; Huchon, G; Bassaris, H; Hampel, B; Reimnitz, P
      A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    74. Anzueto, A
      Untitled

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    75. Landen, H; Moller, M; Tillotson, GS; Kubin, R; Hoffken, G
      Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    76. Lorenz, J; Busch, W; Thate-Waschke, IM
      Moxifloxacin in acute exacerbations of chronic bronchitis: Clinical evaluation and assessment by patients

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    77. Lorenz, J; Thate-Waschke, IM; Mast, O; Kubin, R; Rychlik, R; Pfeil, T; Daniel, D; Tillotson, GS
      Treatment outcomes in acute exacerbations of chronic bronchitis: Comparison of macrolides and moxifloxacin from the patient perspective

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    78. Adkison, JD; Konzem, SL
      Management of acute exacerbations of chronic obstructive pulmonary disease

      PHARMACOTHERAPY
    79. Fish, DN
      Fluoroquinolone adverse effects and drug interactions

      PHARMACOTHERAPY
    80. Yerxa, BR
      Therapeutic use of nucleotides in respiratory and ophthalmic diseases

      DRUG DEVELOPMENT RESEARCH
    81. Danuser, B; Weber, C; Kunzli, N; Schindler, C; Nowak, D
      Respiratory symptoms in Swiss farmers: An epidemiological study of risk factors

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    82. Kimbell-Dunn, MR; Fishwick, RD; Bradshaw, L; Erkinjuntti-Pekkanen, R; Pearce, N
      Work-related respiratory symptoms in New Zealand farmers

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    83. Polosukhin, VV; Manouilova, LS; Romberger, DJ; Matthews, KI; Pirruccello, SJ; West, W; Daughton, DM; Millatmal, T; Umino, T; Rennard, SI
      Ultrastructural heterogeneity of the alveolar macrophages from tobacco smokers with chronic bronchitis

      ULTRASTRUCTURAL PATHOLOGY
    84. Moller, W; Barth, W; Kohlhaufl, M; Haussinger, K; Stahlhofen, W; Heyder, J
      Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects

      EXPERIMENTAL LUNG RESEARCH
    85. Adam, D; Glaser-Caldow, E; Wachter, J; Brueckner, OJ; Hein, J; Kroemer, B; Hirsch, J
      Comparative efficacy of clarithromycin modified-release and clarithromycinimmediate-release formulations in the treatment of lower respiratory tractinfection

      CLINICAL THERAPEUTICS
    86. Saint, S; Flaherty, KR; Abrahamse, P; Martinez, FJ; Fendrick, AM
      Acute exacerbation of chronic bronchitis: Disease-specific issues that influence the cost-effectiveness of antimicrobial therapy

      CLINICAL THERAPEUTICS
    87. Fendrick, AM; Saint, S; Brook, I; Jacobs, MR; Pelton, S; Sethi, S
      Diagnosis and treatment of upper respiratory tract infections in the primary care setting

      CLINICAL THERAPEUTICS
    88. Anzueto, A; Fisher, CL; Busman, T; Olson, CA
      Comparison of the efficacy of extendled-release clarithromycin tablets andamoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis

      CLINICAL THERAPEUTICS
    89. Gotfried, MH; DeAbate, CA; Fogarty, C; Mathew, CP; Sokol, WN
      Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

      CLINICAL THERAPEUTICS
    90. Nouira, S; Marghli, S; Belghith, M; Besbes, L; Elatrous, S; Abroug, F
      Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial

      LANCET
    91. Selnes, A; Odland, JO; Bolle, R; Holt, J; Dotterud, LK; Lund, E
      Asthma and allergy in Russian and Norwegian schoolchildren: results from two questionnaire-based studies in the Kola Peninsula, Russia, and northern Norway

      ALLERGY
    92. Kotaniemi, JT; Lundback, B; Nieminen, MM; Sovijarvi, ARA; Laitinen, LA
      Increase of asthma in adults in northern Finland? a report from the FinEsSstudy

      ALLERGY
    93. Mitsunobu, F; Mifune, T; Hosaki, Y; Ashida, K; Tsugeno, H; Okamoto, M; Takata, S; Tanizaki, Y
      Enhanced production of leukotrienes by peripheral leukocytes and specific IgE antibodies in patients with chronic obstructive pulmonary disease

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    94. Klepser, ME; Ernst, EJ; Petzold, CR; Rhomberg, P; Doern, GV
      Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    95. Pavlovic, M; Spasojevic, M; Tasic, Z; Tacevic, S
      Bronchial hyperactivity in bakers and its relation to atopy and skin reactivity

      SCIENCE OF THE TOTAL ENVIRONMENT
    96. Ait-Khaled, N; Enarson, D; Bousquet, J
      Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management

      BULLETIN OF THE WORLD HEALTH ORGANIZATION
    97. Dentener, MA; Creutzberg, EC; Schols, AMWJ; Mantovani, A; van't Veer, C; Buurman, WA; Wouters, EFM
      Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations

      THORAX
    98. Maestrelli, P; Richeldi, L; Moretti, M; Fabbri, LM
      Analysis of sputum in COPD

      THORAX
    99. Qvarfordt, I; Riise, GC; Andersson, BA; Larsson, S
      IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations

      THORAX
    100. Woolhouse, IS; Hill, SL; Stockley, RA
      Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis

      THORAX


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 22:19:56